What should not be taken with Erlotinib Hydrochloride Tablets?
Erlotinib hydrochloride tablets, as an anti-lung cancer targeted drug, are mainly used to treat advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations. While taking erlotinib hydrochloride tablets, patients need to be careful to avoid taking it with certain foods and drugs to ensure the safety and effectiveness of the treatment. The following are the main items that should not be taken with erlotinib hydrochloride tablets:
1. Specific drugs:
1.Warfarin: When Erlotinib Hydrochloride Tablets are used together with warfarin, very serious or even fatal bleeding may occur. Therefore, if patients are taking warfarin, they should undergo strict blood tests and communicate closely with their doctors.
2.Enzyme inhibitors and enzyme inducers: Certain drugs, such as enzyme inhibitors such as paclitaxel, may prevent the normal metabolism of erlotinib and increase its concentration in the body, thus increasing the risk of adverse reactions. Enzyme inducers, such as rifampin, may reduce the efficacy of erlotinib. Therefore, caution should be used when using erlotinib with these drugs, and the patient's response should be closely monitored.
3.Antacid drugs: such as omeprazole, may reduce the bioavailability of erlotinib hydrochloride tablets and affect the efficacy.
2. Food:
1.Grapefruit and grapefruit juice: may affect the metabolism of erlotinib and should be avoided while taking erlotinib.
2.High-fat diet: may slow down the absorption rate of erlotinib hydrochloride tablets and reduce its bioavailability. Therefore, it is recommended to avoid high-fat diets.
3. Other matters needing attention:
For patients who smoke, smoking will result in reduced exposure to erlotinib, which may affect efficacy. Therefore, it is best to quit smoking while taking the medication, or discuss with your doctor whether the dosage of the medication needs to be adjusted.
Foods or medicines containing lactose: Because erlotinib hydrochloride tablets contain lactose, this medicine should be avoided in patients with rare genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)